Abstract
The published neurosurgical literature remains unclear as to whether the extent of surgical resection statistically correlates with survival. The possible sources of this current state of confusion and lack of concordance between studies are numerous: different distributions of covariates, different classification criteria, differences in patient selection, and various methodological flaws. Almost all of the modern studies are retrospective and thus subject to numerous sources of bias and variation. Additional retrospective studies and poorly designed prospective studies will not clarify the effect of extent of surgery on survival. In the absence of randomized experiments with well-defined protocols for aggressive and conservative surgery, well-planned and carefully executed prospective observational studies are needed. In the meantime, we are left with the conclusion that little scientifically credible evidence is available to support the assertion that aggressive surgical resection prolongs survival.
Similar content being viewed by others
References
Nazzaro JM, Neuwelt EA: The role of surgery in the management of supratentorial intermediate and high-grade astrocytoma in adults. J Neurosurg 73: 331–344, 1990
Quigley MR, Maroon JC: The relationship between survival and the extent of the resection in patients with supratentorial malignant gliomas. Neurosurgery 29: 385–389, 1991
Salcman M:Surgery for malignant gliomas. In: Morantz RA, Walsh JW (eds) Brain Tumors: A Comprehensive Text. Marcel Dekker, New York, 1994, pp 417–427
Cohadon F: Indications for surgery in the management of gliomas. Adv Tech Stand Neurosurg 17: 189–234, 1990
Nitta T, Sato K: Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas. Cancer 75: 2727–2731, 1995
Kelly PJ, Hunt C: The limited value of cytoreductive surgery in elderly patients with malignant gliomas. Neurosurgery 34: 62–67, 1994
Devaux BC, O'Fallon JR, Kelly PJ: Resection, biopsy, and survival in malignant glial neoplasms: a retrospective study of clinical parameters, therapy and outcome. J Neurosurg 78: 767–775, 1993
Bruner JM: Neuropathology of malignant gliomas. Seminars in Oncology 21: 126–138, 1994
Wood JR, Green SB, Shapiro WR: The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group. J Clin Oncol 6: 338–343, 1988
Kiwit JCW, Floeth FW, Bock WJ: Survival in malignant glioma: analysis of prognostic factors with special regard to cytoreductive surgery. Zentralbl Neurochir 57: 76–88, 1996
Chisholm RA, Stenning S, Hawkings TD: The accuracy of volumetric measurement of high-grade gliomas. Clinical Radiology 40: 17–21, 1989
Albert FK, Forsting M, Sartor K, Adams H-P, Kunze S: Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 34: 45–61, 1994
Kreth FW, Warnke PC, Scheremet R, Ostertag CB: Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg 78: 762–766, 1993
Simon R, Altman DG:Statistical aspects of prognostic factor studies in oncology. Br J Cancer 69: 979–985, 1994
Curran WJ, Scott CB, Horton J, Nelson JS, Weinstein AS, Nelson DF, Fischbach AJ, Chang CH, Rotman M, Asbell SO, Powlis WD: Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group 231 (RTOG) trials. Journal of Neuro-Oncology 12: 219–227, 1992
Prados MD, Gutin PH, Phillips TL, Wara WM, Larson DA, Sneed PK, Davis RL, Ahn DK, Lamborn K, Wilson CB: Highly anaplastic astrocytoma: a review of 357 patients treated between 1977 and 1989. In J Radiation Oncology Biol Phys 23: 3–8, 1992
Lai D-M, Lin S-M, Tu Y-K, Kao M-C, Hung C-C: Therapy for supratentorial malignant astrocytomas: survival and possible prognostic factors. J Formos Med Assoc 92: 220–226, 1993
Van der Linden W: Pitfalls in randomized surgical trials. Surgery 87: 258–262, 1980
Gray-Donald K, Kramer MS: Causality inference in observational vs. Experimental studies: an empirical comparison. Am J Epidemiology 127: 885–892, 1988
Walker MD, Green SB, Byar DP, Alexander E, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS, Mealey J, Owens G, Ransohoff J, Robertson JT, Shapiro WR, Smith KR, Wilson CB, Strike TA: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303: 1323–1329, 1980
Shapiro WR, Green SB, Burger PC, Mahaley MS, Selker RG, VanGilder JC, Robertson JT, Ransohoff J, Mealey J, Strike TA, Pistenmaa DA: Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma: Brain Tumor Cooperative Group Trial 8001. J Neurosurg 71: 1–9, 1989
Koprowski C: Confounding factors in clinical studies of gliomas. Am J Clin Oncol 10: 293–295, 1987
Hutchinson TA, Boyd NF, Feinstein AR, Gonda A, Hollomby D, RowatB: Scientific problems in clinical scales, as demonstrated in the Karnofsky index of performance status 32: 661–666, 1979